Tracheobronchitis

This trial is testing an investigational drug called brenipatide in adults with moderate-to-severe COPD. Participants will receive either brenipatide or a placebo for about a year, alongside standard care. The goal is to see if brenipatide improves lung function and reduces the n…

This study tests whether a 5-day course of inhaled amikacin can prevent ventilator-associated pneumonia in critically ill patients who already have a milder airway infection called tracheobronchitis. 250 adults on breathing machines will receive either the drug or a placebo. The …

This study tests whether it is safe to repeat a procedure called metered cryospray in people with COPD and chronic bronchitis who have already had it once. Only 10 participants will be enrolled. The main goal is to see if the treatment can be fully delivered and to track any seri…

This Phase 3 trial tests an experimental drug called AG2001 in 300 adults with acute bronchitis. Participants take the drug three times daily for 7 days. The goal is to see if AG2001 reduces cough and mucus better than two other active drugs by day 4. The study is not yet recruit…

This study follows adults hospitalized with a lower respiratory tract infection, such as pneumonia or bronchitis, to measure how their quality of life changes over one year. Researchers use a standard questionnaire to track physical, mental, and social well-being at several point…

This study tests whether discharge education materials created with the help of artificial intelligence can better prepare mothers to care for children hospitalized with bronchitis or bronchiolitis. Mothers are randomly assigned to receive either AI-assisted written or video educ…